Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06747117 · ClinicalTrials.gov registry record
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
A clinical trial of Lower Extremity Acute Limb Ischemia and LE ALI, sponsored by Penumbra.
- Recruiting
- Registry status
- 300
- Enrollment target
- 20
- Study locations
NCT06747117: Recruiting study of Lower Extremity Acute Limb Ischemia and LE ALI, sponsored by Penumbra.
NCT06747117 is a study of Lower Extremity Acute Limb Ischemia and LE ALI that is actively recruiting participants, run by Penumbra. The registered enrollment target is 300 participants. The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06747117, a study of Lower Extremity Acute Limb Ischemia and LE ALI, is actively recruiting participants, sponsored by Penumbra.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo™ Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).
Conditions Studied
Interventions
- DEVICE Indigo Aspiration System
Study Locations (20)
Florida
- University of Florida Shands Hospital - Gainesville
- Radiology and Imaging Specialists - Lakeland
- Baptist Hospital of Miami, Miami Cardiac and Vascular Institute - Miami
Ohio
- TriHealth Good Samaritan Hospital - Cincinnati
- Cleveland Clinic - Cleveland
South Carolina
- Prisma Health Greenville Memorial Hospital - Greenville
- Lexington Medical Center - West Columbia
Texas
- Baylor St. Luke's Medical Center - Houston
- Baylor Scott & White The Heart Hospital - Plano - Plano
Arizona
- HonorHealth Scottsdale Osborn Medical Center - Scottsdale
California
- Community Memorial Hospital - Ventura
Connecticut
- Yale New Haven Hospital - New Haven
Delaware
- Christiana Care Health Services, Inc. - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-05-18 |
| Est. Completion | 2029-01 |
What NCT06747117 shows while recruiting
NCT06747117 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Lower Extremity Acute Limb Ischemia appearing as the primary indexed condition, and to 1 intervention - of which Indigo Aspiration System is the first listed.
NCT06747117 names 20 study sites across 15 states, led by Florida, Ohio, South Carolina.
Frequently Asked Questions
What is clinical trial NCT06747117 about?
NCT06747117 is a clinical study titled "A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)". The primary objective of this study is to collect and evaluate clinical evidence supporting the safety and performance of the Indigo™ Aspiration System in a patient population with lower extremity acute limb ischemia (LE ALI).
What is the current status of trial NCT06747117?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-05-18. Estimated completion is 2029-01.
What conditions does trial NCT06747117 study?
This clinical trial studies the following conditions: Lower Extremity Acute Limb Ischemia, LE ALI.
What interventions are being tested in trial NCT06747117?
The interventions under investigation include: Indigo Aspiration System (DEVICE).
Who is sponsoring clinical trial NCT06747117?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06747117 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Delaware, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI